---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-135949"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:07:56.593053+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Verrica stockholders elect three directors, approve reverse split authorization at annual meeting

## Summary
- Elected directors Sean Stalfort (60.3M for), Diem Nguyen (58.8M for), Gavin Corcoran (63.0M for).
- Advisory vote on named executive officer compensation approved: 62.4M for, 1.3M against.
- Ratification of KPMG LLP as auditor for FY2025 approved: 81.9M for, 1.5M against.
- Approved reverse stock split authorization at ratio of 1-for-10 to 1-for-30, board discretion.

## SEC filing metadata
- accession: 0001193125-25-135949
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312525135949/0001193125-25-135949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312525135949/d82912d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-135949
- JSON: https://secwatch.observer/filing/0001193125-25-135949.json
- Plain text: https://secwatch.observer/filing/0001193125-25-135949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.